Document Detail


A New Liquid Human Milk Fortifier and Linear Growth in Preterm Infants.
MedLine Citation:
PMID:  22987877     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES:To evaluate the growth, tolerance, and safety of a new ultraconcentrated liquid human milk fortifier (LHMF) designed to provide optimal nutrients for preterm infants receiving human breast milk in a safe, nonpowder formulation.METHODS:Preterm infants with a body weight ≤1250 g fed expressed and/or donor breast milk were randomized to receive a control powder human milk fortifier (HMF) or a new LHMF for 28 days. When added to breast milk, the LHMF provided ∼20% more protein than the control HMF. Weight, length, head circumference, and serum prealbumin, albumin, blood urea nitrogen, electrolytes, and blood gases were measured. The occurrence of sepsis, necrotizing enterocolitis, and serious adverse events were monitored.RESULTS:This multicenter, third party-blinded, randomized controlled, prospective study enrolled 150 infants. Achieved weight and linear growth rate were significantly higher in the LHMF versus control groups (P = .04 and 0.03, respectively). Among infants who adhered closely to the protocol, the LHMF had a significantly higher achieved weight, length, head circumference, and linear growth rate than the control HMF (P = .004, P = .003, P = .04, and P = .01, respectively). There were no differences in measures of feeding tolerance or days to achieve full feeding volumes. Prealbumin, albumin, and blood urea nitrogen were higher in the LHMF group versus the control group (all P < .05). There was no difference in the incidence of confirmed sepsis or necrotizing enterocolitis.CONCLUSIONS:Use of a new LHMF in preterm infants instead of powder HMF is safe. Benefits of LHMF include improvements in growth and avoidance of the use of powder products in the NICU.
Authors:
Fernando Moya; Paula M Sisk; Kelly R Walsh; Carol Lynn Berseth
Related Documents :
23916057 - Preoperative left ventricular internal dimension in end-diastole as earlier identificat...
24875407 - Parathyroid hormone as a marker for metabolic bone disease of prematurity.
24642757 - Prevalence of small-for-gestational-age and its mortality risk varies by choice of birt...
12219057 - Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight...
21114527 - Feasibility and compliance in a nutritional primary prevention trial in infants at incr...
19251927 - Genetic parameters and factors influencing survival to twenty-four hours after birth in...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-17
Journal Detail:
Title:  Pediatrics     Volume:  -     ISSN:  1098-4275     ISO Abbreviation:  Pediatrics     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376422     Medline TA:  Pediatrics     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Coastal Carolina Neonatology, Wilmington, North Carolina;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Circulating 25-Hydroxyvitamin D3 in Pregnancy and Infant Neuropsychological Development.
Next Document:  Variability of growth in children starting antiretroviral treatment in southern Africa.